2017Zhonghua laonian yixue zazhiRequires access

Expression level and its clinical significance of human epidermal growth factor receptor 2, estrogen receptor, progesterone receptor, P53 and Ki-67 in breast cancer tissues of elderly patients

Tanwei Fang, Ruifa Feng

Open publisher page 0 citations

Abstract

Objectives To investigate the expression level and its clinical significance of human epidermal growth factor receptor 2(C-erbB-2), estrogen receptor(ER), progesterone receptor(PR), Ki67 and P53 in breast cancer tissues of elderly patients. Methods The expressions of C-erbB-2, ER, PR, Ki67 and P53 in 103 specimens of breast cancer tissues were assessed by immunohistochemistry(S-P), and their relationships with clinicopathological factors including tumor size, lymph node metastasis status and clinical stages were statistically analyzed. Results The positive rate of C-erbB-2, ER, PR, Ki67 and P53 in 103 cases was 17.5%(18/103), 64.1%(66/103), 54.4%(56/103), 70.9%(73/103)and 66.0%(68/103), respectively.The positive expression rates of C-erbB-2 and P53 were correlated with clinical stages and lymph node metastasis status(P 0.05). The positive expression rates of C-erbB-2, P53, ER and PR were irrelevant to tumor size(P>0.05). Conclusions The expression of C-erbB-2, ER, PR, Ki67 and P53 could be biological markers for estimating the occurrence and progression of elderly breast cancer.Detection of C-erbB-2, ER, PR, Ki67 and P53 may help judge the clinical stages and lymph node metastasis status in elderly patients with breast cancer. Key words: Breast neoplasms; Tumor markers, biological

About this research paper

What this paper is about

Objectives To investigate the expression level and its clinical significance of human epidermal growth factor receptor 2(C-erbB-2), estrogen receptor(ER), progesterone receptor(PR), Ki67 and P53 in breast cancer tissues of elderly patients. Methods The expressions of C-erbB-2, ER, PR, Ki67 and P53 in 103 specimens of breast cancer tissues were assessed by immunohistochemistry(S-P), and their relationships with clinicopathological factors including tumor size, lymph node metastasis status and clinical stages were statistically analyzed. Results The positive rate of C-erbB-2, ER, PR, Ki67 and P53 in 103 cases was 17.5%(18/103), 64.1%(66/103), 54.4%(56/103), 70.9%(73/103)and 66.0%(68/103), respectively.The positive expression rates of C-erbB-2 and P53 were correlated with clinical stages and lymph node metastasis status(P 0.05). The positive expression rates of C-erbB-2, P53, ER and PR were irrelevant to tumor size(P>0.05). Conclusions The expression of C-erbB-2, ER, PR, Ki67 and P53 could be biological markers for estimating the occurrence and progression of elderly breast cancer.Detection of C-erbB-2, ER, PR, Ki67 and P53 may help judge the clinical stages and lymph node metastasis status in elderly patients with breast cancer. Key words: Breast neoplasms; Tumor markers, biological

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives To investigate the expression level and its clinical significance of human epidermal growth factor receptor 2(C-erbB-2), estrogen receptor(ER), progesterone receptor(PR), Ki67 and P53 in breast cancer tissues of elderly patients. Methods The expressions of C-erbB-2, ER, PR, Ki67 and P53 in 103 specimens of breast cancer tissues were assessed by immunohistochemistry(S-P), and their relationships with clinicopathological factors including tumor size, lymph node metastasis status and clinical stages were statistically analyzed. Results The positive rate of C-erbB-2, ER, PR, Ki67 and P53 in 103 cases was 17.5%(18/103), 64.1%(66/103), 54.4%(56/103), 70.9%(73/103)and 66.0%(68/103), respectively.The positive expression rates of C-erbB-2 and P53 were correlated with clinical stages and lymph node metastasis status(P 0.05). The positive expression rates of C-erbB-2, P53, ER and PR were irrelevant to tumor size(P>0.05). Conclusions The expression of C-erbB-2, ER, PR, Ki67 and P53 could be biological markers for estimating the occurrence and progression of elderly breast cancer.Detection of C-erbB-2, ER, PR, Ki67 and P53 may help judge the clinical stages and lymph node metastasis status in elderly patients with breast cancer. Key words: Breast neoplasms; Tumor markers, biological

Key concepts: Breast cancer, Estrogen receptor, Progesterone receptor, Immunohistochemistry, Medicine, Epidermal growth factor receptor, Lymph node, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression level and its clinical significance of human epidermal growth factor receptor 2, estrogen receptor, progesterone receptor, P53 and Ki-67 in breast cancer tissues of elderly patients — Research Paper | ScholarLens